Published on 19 Apr 2024 on Simply Wall St. via Yahoo Finance
Over the last year, a good number of insiders have significantly increased their holdings in IGM Biosciences, Inc. (NASDAQ:IGMS). This is encouraging because it indicates that insiders are more optimistic about the company's prospects.
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.